Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 14/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | SLC43A1 | O75387 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7162756 | 0.91 | ALDH1A1 (0.40) | ALDH1A1NPC1CHRNB2CHRNA5CHRNA7 | |
| SCHEMBL14615902 | 0.83 | ALDH1A1 (0.44) | ALDH1A1NPC1ABCB1SLC43A1 | |
| SCHEMBL12112020 | 0.81 | ALDH1A1 (0.44) | ALDH1A1NPC1ABCB1SLC43A1 | |
| SCHEMBL12111919 | 0.81 | ALDH1A1 (0.44) | ALDH1A1NPC1ABCB1SLC43A1 | |
| SCHEMBL7161077 | 0.80 | ALDH1A1 (0.39) | ALDH1A1NPC1ABCB1CHRNB2CHRNA5 | |
| SCHEMBL7159960 | 0.79 | ALDH1A1 (0.39) | ALDH1A1NPC1ABCB1SLC43A1 | |
| SCHEMBL20557502 | 0.78 | ALDH1A1 (0.45) | ALDH1A1NPC1ABCB1CHRNB2CHRNA5 | |
| SCHEMBL16576324 | 0.78 | ALDH1A1 (0.45) | ALDH1A1NPC1ABCB1CHRNB2CHRNA5 | |
| SCHEMBL27087661 | 0.78 | ALDH1A1 (0.45) | ALDH1A1NPC1ABCB1CHRNB2CHRNA5 | |
| SCHEMBL7161159 | 0.77 | ALDH1A1 (0.39) | ALDH1A1NPC1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0747389-B1 | 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES | TAIHO PHARMACEUTICAL CO LTD (JP) | 2003-09-10 | — | — | EP | disclosed |
| US-RE38090-E1 | Antitumor activity; useful for treatment and prevention of cancers | Matsuda, Akira (JP) | 2003-04-22 | — | — | US | disclosed |
| US-5763418-A | NUCLEOTIDE ANTITUMOR AGENTS | Matsuda, Akira (JP) | 1998-06-09 | — | — | US | disclosed |
| EP-0747389-A1 | 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1996-12-11 | — | — | EP | disclosed |